Quantitative Prediction of Right Ventricular Size and Function From the ECG
AI-driven study redefines right heart health assessment with novel predictive model using standard 12-lead ECG.
Read PublicationAdvancing the understanding of heart disease detection through rigorous research and peer-reviewed publications.
Most patients with heart disease are asymptomatic until advanced stages.
Physicians have limited front-line technology options to detect heart disease.
Most advanced screening tests are expensive and require specialist referral.
Payors often discourage advanced screening for asymptomatic patients.
License agreements for AI cardiovascular algorithms developed by leading research institutions.
Multi-year collaboration to develop AI-based ECG algorithms for cardiac detection.
Clinical studies validating ECG-based detection of left ventricular dysfunction.
Our AI-ECG algorithms are backed by rigorous peer-reviewed research published in the world's leading cardiology journals.
AI-driven study redefines right heart health assessment with novel predictive model using standard 12-lead ECG.
Read PublicationHeartBEiT, a vision-based transformer model, significantly outperforms standard CNN architectures for cardiac analysis.
Read PublicationAI-ECG models demonstrate improved prediction of adverse outcomes in patients undergoing cardiac surgery.
Read PublicationRequest a demo to see how HeartSciences AI-ECG technology can enhance early detection of heart disease in your practice or health system.
Walk through our 23 peer-reviewed publications and clinical validation data.
See the MyoVista Insights cloud platform and device integration in action.
Discuss integration with your clinical workflows and EHR systems.